Continuous Subcutaneous Insulin Infusion Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The CSII market comprises medical devices that deliver rapid- or short-acting insulin continuously through a catheter placed under the skin, offering an alternative to multiple daily insulin injections. These systems include traditional tethered pumps connected by tubing and tubeless patch pumps that adhere directly to the skin. The technology serves both Type 1 and Type 2 diabetes patients who require intensive insulin therapy, with adoption rates climbing as clinical evidence demonstrates improved glycemic control and reduced hypoglycemia risk compared to conventional methods.

• •Market valued at $3.1 billion in 2025 with projected 9.8% annual growth through the early 2030s
• •Primary product categories include tethered pumps and patch pumps, with tubeless systems gaining market share
• •Serves both Type 1 diabetes patients (primary users) and insulin-requiring Type 2 patients
• •Integration with continuous glucose monitoring (CGM) systems is becoming standard in new device generations

The global diabetes epidemic remains the primary market catalyst, with the International Diabetes Federation estimating over 500 million adults living with diabetes worldwide, creating sustained demand for advanced delivery systems. Technological innovations including closed-loop automated insulin delivery systems, smartphone connectivity, and improved battery life are accelerating replacement cycles and attracting new users. Additionally, favorable reimbursement policies in developed markets and expanding healthcare infrastructure in emerging economies support broader market penetration.

• •Rising global diabetes prevalence, particularly Type 2 diabetes requiring intensive insulin therapy
• •Advancements in automated insulin delivery and artificial pancreas technology
• •Growing preference for tubeless patch pump systems due to improved convenience and discretion
• •Increased healthcare expenditure and insurance coverage for diabetes management devices

The market segments primarily by product type, with tethered pumps holding the largest share due to established provider familiarity and feature sets, while patch pumps represent the fastest-growing segment. Geographically, North America dominates with approximately 40% of global revenue, supported by advanced healthcare infrastructure and high diabetes diagnosis rates. Europe follows as the second-largest market, while Asia-Pacific emerges as the fastest-growing region driven by rising diabetes incidence in China and India, improving economic conditions, and expanding medical device adoption.

• •Product segments: Traditional tethered pumps (largest share) versus patch pumps (fastest growth)
• •Patient segments: Type 1 diabetes (primary segment) and Type 2 diabetes requiring intensive insulin therapy
• •Regional distribution: North America leads, followed by Europe, with Asia-Pacific showing highest growth momentum
• •End-use channels: Hospitals and clinics for initial device education, home care for ongoing use

What are the recent trends and outlook?

The market trajectory points toward continued growth as closed-loop automated insulin delivery systems become more sophisticated and accessible, potentially expanding the addressable patient population beyond current insulin pump users. Integration of artificial intelligence and machine learning for predictive glucose management represents the next technological frontier. Additionally, the shift toward value-based healthcare is encouraging outcomes-focused pricing models and patient support programs to demonstrate clinical and economic benefits.

• •Growing adoption of automated insulin delivery systems with reduced patient intervention requirements
• •Expansion of digital health platforms enabling remote monitoring and telemedicine integration
• •Development of smaller, longer-lasting devices with improved patient comfort and discretion
• •Potential market disruption from next-generation biotech therapies and non-invasive delivery methods